Renee Tannenbaum

Track

Insider profile

Currently holds a position at Zogenix Inc

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 95% 68% 82%
Transactions
5 60% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Zogenix Inc Jan. 1, 2017 -
Independent Director Sharps Compliance Corp Feb. 29, 2012 - Nov. 19, 2015
Director Zogenix Inc Feb. 10, 2015 - June 18, 2015
Renee Tannenbaum's trades of ANI Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-09 2025-12-05
PrS Proposed sale
16,868
229.53
US$3,442,508 		16,868 229.53 US$3,442,508
2025-12-09 2025-12-05
S Sale
92,735 -12.7%
498.26
US$2,519,937 		92,735 -12.7% 498.26 US$2,519,937
2024-12-16 2024-12-12
B Purchase
85,526 -43.9%
317.12
US$2,802,529 		85,526 -43.9% 317.12 US$2,802,529
2024-05-17 2024-05-16
S Sale
2,000 -9.9%
63.87
US$127,740 		2,000 -9.9% 63.87 US$127,740
2024-05-16 2024-05-16
PrS Proposed sale
2,000
63.87
US$127,733 		2,000 63.87 US$127,733
2022-09-19 2022-09-15
B Purchase
3,600 +56.2%
1.72
US$6,192 		3,600 +56.2% 1.72 US$6,192
2022-09-19 2022-09-15
B Purchase
6,400 +inf%
1.72
US$10,976 		6,400 +inf% 1.72 US$10,976
2021-11-30 2021-11-29
US Zogenix Inc (ZGNX)
S Sale
5,305 -14.0%
11.72
US$62,175 		5,305 -14.0% 11.72 US$62,175
2021-06-03 2021-06-01
US Zogenix Inc (ZGNX)
B Purchase
5,000 +15.2%
17.05
US$85,248 		5,000 +15.2% 17.05 US$85,248
2020-11-18 2020-11-17
US Zogenix Inc (ZGNX)
S Sale
15,000 -31.3%
20.74
US$311,066 		15,000 -31.3% 20.74 US$311,066
2019-03-08 2019-03-06
US Zogenix Inc (ZGNX)
S Sale
17,503 -26.8%
50.65
US$886,474 		17,503 -26.8% 50.65 US$886,474